DOI:
10.1055/s-00034917
Kinder- und Jugendmedizin
LinksClose Window
References
Vickery BP.
Can Omalizumab Monotherapy Benefit Real-World Food Allergy Patients? Lessons from an Observational Study.
J Allergy Clin Immunol Pract 2019;
7 (06) 1910-1911
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.